| Product Code: ETC9169439 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Malignant Pleural Mesothelioma Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Malignant Pleural Mesothelioma Market - Industry Life Cycle |
3.4 Saudi Arabia Malignant Pleural Mesothelioma Market - Porter's Five Forces |
3.5 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Saudi Arabia Malignant Pleural Mesothelioma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about malignant pleural mesothelioma and early detection campaigns |
4.2.2 Advancements in diagnostic technologies and treatment options |
4.2.3 Growing healthcare infrastructure and availability of specialized treatment centers |
4.3 Market Restraints |
4.3.1 Limited availability of specialized medical professionals for mesothelioma treatment |
4.3.2 High treatment costs and limited insurance coverage for mesothelioma therapies |
4.3.3 Lack of standardized protocols for mesothelioma diagnosis and treatment in Saudi Arabia |
5 Saudi Arabia Malignant Pleural Mesothelioma Market Trends |
6 Saudi Arabia Malignant Pleural Mesothelioma Market, By Types |
6.1 Saudi Arabia Malignant Pleural Mesothelioma Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, By Opdivo (Nivolumab), 2021- 2031F |
6.1.4 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, By Yervoy (Ipilimumab), 2021- 2031F |
6.1.5 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, By MTG201, 2021- 2031F |
6.1.6 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, By CBP501, 2021- 2031F |
6.1.7 Saudi Arabia Malignant Pleural Mesothelioma Market Revenues & Volume, By Lurbinectedin, 2021- 2031F |
7 Saudi Arabia Malignant Pleural Mesothelioma Market Import-Export Trade Statistics |
7.1 Saudi Arabia Malignant Pleural Mesothelioma Market Export to Major Countries |
7.2 Saudi Arabia Malignant Pleural Mesothelioma Market Imports from Major Countries |
8 Saudi Arabia Malignant Pleural Mesothelioma Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation |
8.2 Number of clinical trials and research studies focused on mesothelioma in Saudi Arabia |
8.3 Patient survival rates at different stages of mesothelioma |
8.4 Adoption rate of novel treatment modalities for mesothelioma |
8.5 Number of hospitals and healthcare facilities offering specialized mesothelioma care |
9 Saudi Arabia Malignant Pleural Mesothelioma Market - Opportunity Assessment |
9.1 Saudi Arabia Malignant Pleural Mesothelioma Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Saudi Arabia Malignant Pleural Mesothelioma Market - Competitive Landscape |
10.1 Saudi Arabia Malignant Pleural Mesothelioma Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Malignant Pleural Mesothelioma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |